Upgrade to SI Premium - Free Trial

Barclays Reiterates Overweight Rating on Medtronic, Inc. (MDT)

August 19, 2024 10:53 AM
Barclays analyst Matt Miksic reiterated an Overweight rating and $104.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles